covid 19 News and Research

RSS

COVID-19 pandemic highlights the key role of biodiversity collections

Events such as the COVID-19 pandemic have highlighted the crucial role played by biodiversity collections in enabling rapid responses to crises and in facilitating ongoing research across numerous fields.

7 Apr 2021

Global secretive governments are bypassing rules during COVID-19 pandemic

From Brazil to the Philippines, secretive governments across the world are responding to the COVID-19 pandemic by covering up data and bypassing public procurement rules, undermining trust in health systems, fuelling anti-vaxxers and putting immunisation campaigns at risk.

7 Apr 2021

Dramatic cuts to UK foreign aid budgets undermine global research partnerships

Dramatic cuts to UK foreign aid budgets have left the future of hundreds of research projects in developing countries hanging in the balance and trusted partnerships severely undermined, say leading scientists.

7 Apr 2021

Second Radiometer donation to support Red Cross COVID19 response

Acknowledging the impact that COVID-19 has on communities and economies globally, we are pleased to announce our second monetary donation to the Danish Red Cross’ international COVID-19 response of DKK 50,000 (USD 7,900) on World Health Day 7 April.

From Radiometer Medical 7 Apr 2021

South African and Brazilian SARS-CoV-2 variants can evade antibodies from therapies, vaccines, and infection

Researchers at the Infection Biology Unit, German Primate Center, and the Georg-August-University Göttingen in Germany have found that the B.1.351 and P.1 SARS-CoV-2 variants have the potential to evade therapeutic antibodies or antibodies induced by natural infection or vaccination.

7 Apr 2021

World Health Day 2021: The humanitarians building a fairer world

In commemoration of World Health Day 2021, News-Medical interviews the International Medical Corps on how they are helping to achieve a fairer and healthier world.

7 Apr 2021

UNION therapeutics’ COVID-19 candidates show promising results in phase 1 study

UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.

7 Apr 2021

CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial

The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial.

7 Apr 2021

Researchers use South Korea Data to create new framework for COVID-19-vulnerable locales

Though the U.S. and South Korea recorded their first official COVID-19 case on the same day, January 20, 2020, there were notable differences in how each country would ultimately address what has become the world's most severe pandemic since 1918.

7 Apr 2021

Antifungal and antidepressant drugs can effectively inhibit COVID-19 virus

New research published in the British Journal of Pharmacology indicates that two currently available medications--an antifungal drug and an antidepressant--can effectively inhibit the virus that causes COVID-19 in laboratory cells.

7 Apr 2021

COVID-19 pandemic provides rare opportunity to learn about human-nature interactions

The COVID-19 pandemic and the global response to it have changed many of the interactions that humans have with nature, in both positive and negative ways.

7 Apr 2021

Pandemic had motivated older adults to discuss care planning, shows survey

As the toll of COVID-19 continues to climb, newly released poll data suggest an opportunity to use the pandemic as a prompt for discussing and documenting older adults' wishes for their care, if they get seriously ill or injured for any reason.

7 Apr 2021

Expert calls for swift action to avoid chronic health conditions caused by COVID-19

A tsunami of chronic health conditions as a result of the SARS-CoV-2 pandemic, especially cardiometabolic disease, may produce an enormous wave of death and disability that demands immediate, comprehensive strategies.

7 Apr 2021

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

The coronavirus disease (COVID-19) first emerged in late December 2019 in Wuhan, China. Though it has been more than one year since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported, it is still unclear how long the antibodies persist in those who have recovered.

7 Apr 2021

COVID-19 pandemic-related restrictions significantly impact bean production

A new study analyzing bean production and food security across 11 countries in sub-Saharan Africa, found COVID-19 pandemic-related restrictions to significantly impact bean production.

7 Apr 2021

COVID-19 infection linked to neurological and mental health conditions

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

7 Apr 2021

COVID-19 pandemic can be used as a prompt for discussing older adults' wishes for end-of-life care

7 Apr 2021

Study: Multidrug-resistant fungus that infests hospitals may have emerged from the wild

C. auris, a drug-resistant fungus that infests hospitals, may have emerged from the wild, says study. Researchers confirmed the presence in the wild of Candida auris, a multidrug-resistant fungus commonly found infesting hospitals.

7 Apr 2021

COVID-19 pandemic provides a wake-up call to control air pollution

A new commentary published online in the Annals of the American Thoracic Society provides an exhaustive examination of published research that discusses whether air pollution may be linked to worse COVID-19 outcomes.

7 Apr 2021

The GovLab, AFD and Expertise France select 7 projects to address COVID-19 challenges in Africa

Out of a field of over 80 proposals by organizations in Africa -- many working in collaboration -- The Governance Lab (GovLab) at the NYU Tandon School of Engineering, L'Agence Francaise de Developpement (AFD), and Expertise France chose seven projects to receive the #Data4COVID19 Africa Challenge.

7 Apr 2021

covid 19 News and Research

COVID-19 pandemic highlights the key role of biodiversity collections

Global secretive governments are bypassing rules during COVID-19 pandemic

Dramatic cuts to UK foreign aid budgets undermine global research partnerships

Second Radiometer donation to support Red Cross COVID19 response

South African and Brazilian SARS-CoV-2 variants can evade antibodies from therapies, vaccines, and infection

World Health Day 2021: The humanitarians building a fairer world

UNION therapeutics’ COVID-19 candidates show promising results in phase 1 study

CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial

Researchers use South Korea Data to create new framework for COVID-19-vulnerable locales

Antifungal and antidepressant drugs can effectively inhibit COVID-19 virus

COVID-19 pandemic provides rare opportunity to learn about human-nature interactions

Pandemic had motivated older adults to discuss care planning, shows survey

Expert calls for swift action to avoid chronic health conditions caused by COVID-19

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

COVID-19 pandemic-related restrictions significantly impact bean production

COVID-19 infection linked to neurological and mental health conditions

COVID-19 pandemic can be used as a prompt for discussing older adults' wishes for end-of-life care

Study: Multidrug-resistant fungus that infests hospitals may have emerged from the wild

COVID-19 pandemic provides a wake-up call to control air pollution

The GovLab, AFD and Expertise France select 7 projects to address COVID-19 challenges in Africa

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News